Author Archives: donttradeourlivesaway

IP Australia opens public consultation on proposed law changes

By Phillips Ormonde Fitzpatrick,  Lexology  Australia September 12 2017 IP Australia have opened public consultation on five IP policy matters. Four of these policy matters form part of IP Australia’s proposed implementation of the Government’s response to the Productivity Commission’s 2016 Report on Intellectual Property Arrangements. … Continue reading

Posted in Uncategorized | Leave a comment

Is India’s Expedited Examination Of Patents A Big Deal?

By Patralekha Chatterjee, IP Watch In recent days, the Indian news media has been awash with stories about a patent granted within a record 113 days. The norm, till very recently, was anywhere between three to five years and sometimes more. However, … Continue reading

Posted in Fast track patent examination, Uncategorized | Leave a comment

Pharmaceutical Pricing Hostages

By Ellen t’ Hoen, Medicines Law & Policy Ireland seems to be the stage of some of the most bizarre pharmaceutical company behaviour these days. This month, the pharmaceutical company CSL Behring announced it will no longer provide Respreeza (human alpha1-proteinase inhibitor), … Continue reading

Posted in R&D, Uncategorized | Leave a comment

DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C

[Kuala Lumpur, Geneva – 20 September 2017] Malaysia has issued a “government use” licence enabling access to more affordable versions of an expensive and patented medicine to treat hepatitis C. This landmark decision should help the more than 400,000 people living with … Continue reading

Posted in Compulsory Licensing, Hepatitis C, Uncategorized | Leave a comment

This Shield of Patents Protects the World’s Best-Selling Drug

Over Humira’s lifetime, AbbVie has secured more than 100 patents to prevent anyone from attempting to copy the biologic, with $16 billion in annual sales. By Cynthia Koons Humira, a treatment for inflammatory diseases such as rheumatoid arthritis and psoriasis … Continue reading

Posted in Biologics/Biosimilars, Uncategorized | Leave a comment

Letter: Over 30 civil society organisations urge EU to abolish supplementary protection certificates mechanism

Source: MSF Access Campaign In an open letter and open submission, thirty-three civil society organisations have called on the European Commission to abolish the supplementary protection certificates (SPC) mechanism and to stop encouraging the inclusion of SPCs – or similar mechanisms, such … Continue reading

Posted in Patent Term Extension, Uncategorized | Leave a comment

NGOs call for supplementary protection certificates to be abolished

By Carmen Paun 9/11/17, 1:43 PM CET A group of 33 civil society organizations led by Doctors Without Borders today asked the European Commission to abolish supplementary protection certificates (SPCs), which they claim lead to unaffordable medicines prices that stay in place for … Continue reading

Posted in Patent Term Extension, Uncategorized | Leave a comment